| The kappa-opioid receptor: evidence for the different subtypes M Wollemann, S Benyhe, J Simon Life sciences 52 (7), 599-611, 1993 | 147 | 1993 |
| Pain inhibition by endomorphins R Przewłocki, D Łabuz, J Mika, B Przewłocka, C Tomboly, G Toth Annals of the new York Academy of Sciences 897 (1), 154-164, 1999 | 111 | 1999 |
| Pharmaceutical composition and use A Borsodi, Z Furst, S Hosztafi, SE Varga, T Friedmann, S Benyhe, ... US Patent 5,317,022, 1994 | 103 | 1994 |
| Morphine: new aspects in the study of an ancient compound S Benyhe Life sciences 55 (13), 969-979, 1994 | 102 | 1994 |
| Non-opioid actions of opioid peptides M Wollemann, S Benyhe Life sciences 75 (3), 257-270, 2004 | 98 | 2004 |
| Met5‐enkephalin‐Arg 6‐Phe7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain S Benyhe, J Farkas, G Tóth, M Wollemann Journal of neuroscience research 48 (3), 249-258, 1997 | 93 | 1997 |
| Kinetics and physical parameters of rat brain opioid receptors solubilized by digitonin and CHAPS J Simon, S Benyhe, K Abutidze, A Borsodi, M Szüs, G Toth, M Wollemann Journal of neurochemistry 46 (3), 695-701, 1986 | 64 | 1986 |
| In VitroBinding and Signaling Profile of the Novel μ Opioid Receptor Agonist Endomorphin 2 in Rat Brain Membranes M Spetea, K Monory, C Tömböly, G Tóth, E Tzavara, S Benyhe, ... Biochemical and biophysical research communications 250 (3), 720-725, 1998 | 61 | 1998 |
| Solubilization and Characterization of Opioid Binding Sites from Frog (Rana esculenta) Brain J Simon, M Szücs, S Benyhe, A Borsodi, P Zeman, M Wollemann Journal of neurochemistry 43 (4), 957-963, 1984 | 58 | 1984 |
| Structure− activity study on the Phe side chain arrangement of endomorphins using conformationally constrained analogues C Tömböly, KE Kövér, A Péter, D Tourwé, D Biyashev, S Benyhe, ... Journal of medicinal chemistry 47 (3), 735-743, 2004 | 52 | 2004 |
| Characterization of kappa 1 and kappa 2 opioid binding sites in frog (Rana esculenta) brain membrane preparation S Benyhe, E Varga, J Hepp, A Magyar, A Borsodi, M Wollemann Neurochemical research 15 (9), 899-904, 1990 | 50 | 1990 |
| Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof H Schmidhammer, M Spetea, J Schutz, E Greiner, F Schullner, B Sailer, ... US Patent App. 10/519,388, 2005 | 47 | 2005 |
| Noladin ether, a putative endocannabinoid, inhibits μ-opioid receptor activation via CB2 cannabinoid receptors E Páldyová, E Bereczki, M Sántha, T Wenger, A Borsodi, S Benyhe Neurochemistry international 52 (1-2), 321-328, 2008 | 44 | 2008 |
| Pregnancy-induced decrease in the relaxant effect of terbutaline in the late-pregnant rat myometrium: role of G-protein activation and progesterone R Gáspár, E Ducza, A Mihályi, A Márki, Z Kolarovszki-Sipiczki, E Páldy, ... Reproduction 130 (1), 113-122, 2005 | 41 | 2005 |
| Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy M Al-Khrasani, G Orosz, L Kocsis, V Farkas, A Magyar, I Lengyel, ... European journal of pharmacology 421 (1), 61-67, 2001 | 41 | 2001 |
| CB2 cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB2 receptor in pain E Páldy, E Bereczki, M Sántha, T Wenger, A Borsodi, A Zimmer, S Benyhe Neurochemistry international 53 (6-8), 309-316, 2008 | 39 | 2008 |
| Endomorphin-2 with a β-turn backbone constraint retains the potent μ-opioid receptor agonist properties C Tömböly, S Ballet, D Feytens, KE Kövér, A Borics, S Lovas, ... Journal of medicinal chemistry 51 (1), 173-177, 2008 | 39 | 2008 |
| Purification of a kappa-opioid receptor subtype from frog brain J Simon, S Benyhe, J Hepp, A Khan, A Borsodi, M Szucs, ... Neuropeptides 10 (1), 19-28, 1987 | 39 | 1987 |
| In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol Ö Gündüz, A Rizzi, A Baldisserotto, R Guerrini, B Spagnolo, EC Gavioli, ... European journal of pharmacology 539 (1-2), 39-48, 2006 | 35 | 2006 |
| Micromolar concentrations of rimonabant directly inhibits delta opioid receptor specific ligand binding and agonist-induced G-protein activity F Zádor, D Kocsis, A Borsodi, S Benyhe Neurochemistry international 67, 14-22, 2014 | 33 | 2014 |
